Featuring our keynote speaker
Janet Woodcock, M.D.
Director of the FDA's Center for Drug Evaluation and Research
CMPI believes now is the right time to pursue an in-depth conversation about what has been learned since the FDA’s groundbreaking approval and what changes we should expect to see in the immediate future.